Wall Street analysts forecast that Molina Healthcare, Inc. (NYSE:MOH) will post earnings per share (EPS) of $1.63 for the current quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Molina Healthcare’s earnings, with the highest EPS estimate coming in at $1.86 and the lowest estimate coming in at $1.41. Molina Healthcare posted earnings of $1.13 per share during the same quarter last year, which would indicate a positive year over year growth rate of 44.2%. The business is scheduled to issue its next quarterly earnings results on Thursday, November 1st.
According to Zacks, analysts expect that Molina Healthcare will report full-year earnings of $7.51 per share for the current fiscal year, with EPS estimates ranging from $7.49 to $7.52. For the next year, analysts expect that the business will post earnings of $6.77 per share, with EPS estimates ranging from $5.70 to $7.26. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that cover Molina Healthcare.
Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Tuesday, July 31st. The company reported $3.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $1.99. The business had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.67 billion. Molina Healthcare had a negative net margin of 0.26% and a positive return on equity of 23.01%. Molina Healthcare’s quarterly revenue was down 2.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($4.01) EPS.
Several analysts have recently weighed in on MOH shares. Barclays lifted their target price on shares of Molina Healthcare from $105.00 to $125.00 and gave the company an “equal weight” rating in a research report on Thursday, August 2nd. Bank of America upped their target price on shares of Molina Healthcare from $94.00 to $110.00 and gave the stock an “underperform” rating in a research report on Wednesday, August 1st. Zacks Investment Research upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating and set a $120.00 target price on the stock in a research report on Tuesday, July 24th. BMO Capital Markets boosted their price target on shares of Molina Healthcare from $85.00 to $94.00 and gave the stock a “market perform” rating in a research note on Friday, June 1st. Finally, SunTrust Banks boosted their price target on shares of Molina Healthcare to $120.00 and gave the stock a “buy” rating in a research note on Tuesday, July 10th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company’s stock. Molina Healthcare has an average rating of “Hold” and an average target price of $114.15.
NYSE:MOH opened at $149.74 on Tuesday. Molina Healthcare has a 52-week low of $58.66 and a 52-week high of $150.06. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.73. The stock has a market cap of $9.05 billion, a PE ratio of 26.98, a P/E/G ratio of 1.43 and a beta of 1.28.
In other news, insider Norman Nichols sold 4,501 shares of the company’s stock in a transaction on Wednesday, August 8th. The shares were sold at an average price of $127.00, for a total value of $571,627.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ronna Romney sold 200 shares of the company’s stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $138.11, for a total transaction of $27,622.00. The disclosure for this sale can be found here. Insiders sold a total of 9,867 shares of company stock valued at $1,301,992 in the last quarter. 0.65% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vident Investment Advisory LLC increased its position in shares of Molina Healthcare by 1.5% during the second quarter. Vident Investment Advisory LLC now owns 38,230 shares of the company’s stock valued at $3,744,000 after buying an additional 573 shares during the period. First Mercantile Trust Co. boosted its stake in shares of Molina Healthcare by 22.5% during the second quarter. First Mercantile Trust Co. now owns 3,442 shares of the company’s stock valued at $337,000 after purchasing an additional 632 shares during the period. State Board of Administration of Florida Retirement System lifted its stake in Molina Healthcare by 2.8% in the first quarter. State Board of Administration of Florida Retirement System now owns 24,447 shares of the company’s stock worth $1,985,000 after acquiring an additional 669 shares during the period. Great West Life Assurance Co. Can lifted its stake in Molina Healthcare by 1.8% in the first quarter. Great West Life Assurance Co. Can now owns 39,001 shares of the company’s stock worth $3,164,000 after acquiring an additional 674 shares during the period. Finally, Louisiana State Employees Retirement System lifted its stake in Molina Healthcare by 5.8% in the second quarter. Louisiana State Employees Retirement System now owns 12,800 shares of the company’s stock worth $1,254,000 after acquiring an additional 700 shares during the period.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
See Also: Should You Consider an Index Fund?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.